Trial · NCT07911488
The Encora X1™ in a Real World Observational Study
NCT07911488, Recruiting, Encora, Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Encora X1™ in a Real World Observational Study. Trials, record NCT07911488. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911488
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Encora X1™ in a Real World Observational Study
- NCT number
- NCT07911488
- Status
- Recruiting
- Enrollment
- 1,000 participants, estimated
- Lead sponsor
- Encora, Inc.
- Conditions
- Essential Tremor
- Interventions
- Encora X1
- First posted
- 2026-11-02
- Last updated
- 2026-11-05
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in the Bain & Findley Activities of Daily Living (BF-ADL) composite score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 and Post Treatment Weeks 1, 4 and 8 | |
| Primary | Change from baseline in the TETRAS PRO composite score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in the QUEST PRO weighted index score at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in the EQ-5D-5L index value at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in WPAI (Work Productivity and Activity Impairment) domain scores at each scheduled assessment. | Baseline to Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in Patient Global Impression of Severity (PGI-S) at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 and Post Treatment Weeks 1, 4 and 8 | |
| Primary | Evaluation of participant therapy usage up to each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Evaluation of changes in the type, frequency, or dosage of tremor-related medications during the 36-month study period. | Up to 36 months | |
| Primary | Assessment of participant overall experience with the Encora X1™ device through Patient Experience Survey. | Months 1, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 | |
| Primary | Change from baseline in each of the 25 individual Bain & Findley Activities of Daily Living (BF-ADL) item scores at each scheduled assessment. | Baseline to Week 1, Months 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911488
GET https://conductscience.org/api/trials/v1/NCT07911488/registered